Hill, David P <br/><br/>
Cisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance.  [electronic resource] 

 -  BMC cancer  Nov 2019 
 - 1039 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1471-2407 
<br/><br/><label>Standard No.: </label>10.1186/s12885-019-6278-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--therapeutic use<br/>Biological Evolution<br/>Cell Line, Tumor<br/>Cisplatin--therapeutic use<br/>Conserved Sequence<br/>Drug Resistance, Neoplasm--genetics<br/>Epithelial-Mesenchymal Transition--genetics<br/>Female<br/>Gene Expression Profiling<br/>Gene Expression Regulation, Neoplastic<br/>Genomics--methods<br/>Humans<br/>Mice<br/>Rats<br/>Receptors, Androgen--metabolism<br/>Triple Negative Breast Neoplasms--drug therapy